New Hematoma Findings from University of Bern Described (Innovative Strategies for Minimizing Hematoma Risk In Mri-guided Breast Biopsies).

A recent study conducted at the University of Bern in Switzerland focused on minimizing hematoma risk during MRI-guided breast biopsies. The research analyzed 252 biopsies and found that factors such as patient age, distances from the target lesion, and the type of biopsy system used influenced the occurrence of larger hematomas. The study emphasized the importance of strategic procedural planning to enhance patient safety during these procedures. For more information, readers can refer to the original article published in Radiology and Oncology. [Extracted from the article]